Leaflet MIDAZOLAM KALCEKS 1mg / ml solution for injection / infusion
Indicated for: sedation
Route of administration: injectable / infusion
Substance: midazolam (benzodiazepine)
ATC: N05CD08 (Nervous system | Hypnotics and sedatives | Benzodiazepine derivatives)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
This medicine may cause dependence or be misused.
May slow breathing, especially with alcohol or sedatives.
Avoid alcohol during treatment.
Avoid grapefruit and grapefruit juice.
This medicine may have important interactions with other medicines.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Older people may have an increased risk of side effects.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Midazolam is a medication used for sedation, anxiety reduction, sleep induction, and seizure control. It belongs to the benzodiazepine class and works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that decreases brain activity, inducing relaxation and drowsiness.
Midazolam is commonly used in medical or surgical procedures to induce conscious sedation or general anesthesia. It is also used to treat acute seizures, including status epilepticus, and to calm agitated patients in intensive care units.
It can be administered intravenously, intramuscularly, orally, or intranasally, depending on the indication. Its effects are rapid, but its duration is relatively short, making it ideal for use in acute situations.
Common side effects include drowsiness, dizziness, confusion, low blood pressure, and respiratory depression. In high doses or when combined with other central nervous system depressants (such as alcohol or opioids), it can cause severe respiratory depression or even respiratory arrest.
Midazolam must be used under strict medical supervision, and the dosage should be adjusted based on the patient's age, weight, and overall condition. It is contraindicated in individuals with benzodiazepine allergies or severe respiratory insufficiency.
General data about MIDAZOLAM KALCEKS 1mg / ml
- Substance: midazolam
- Date of last drug list: 01-11-2024
- Commercial code: W68139001
- Concentration: 1mg / ml
- Pharmaceutical form: solution for injection / infusion
- Quantity: 10
- Product type: generic
- Prescription restrictions: TAB3 - Medicines that are issued with a special prescription (psychotropic) in green color.
Pharmaceutical forms available for midazolam
Concentrations available for midazolam
- 10mg
- 10mg/2ml
- 1mg/ml
- 2.5mg
- 2.5mg/0.5ml
- 2mg/ml
- 5mg
- 5mg/1ml
- 5mg/ml
- 7.5mg
- 72.5mg/1.5ml